Growth Metrics

Volitionrx (VNRX) Long-Term Deferred Tax (2020 - 2024)

Historic Long-Term Deferred Tax for Volitionrx (VNRX) over the last 5 years, with Q4 2024 value amounting to $41.9 million.

  • Volitionrx's Long-Term Deferred Tax rose 1290.23% to $41.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $41.9 million, marking a year-over-year increase of 1290.23%. This contributed to the annual value of $41.9 million for FY2024, which is 1290.23% up from last year.
  • According to the latest figures from Q4 2024, Volitionrx's Long-Term Deferred Tax is $41.9 million, which was up 1290.23% from $37.1 million recorded in Q4 2023.
  • Volitionrx's Long-Term Deferred Tax's 5-year high stood at $41.9 million during Q4 2024, with a 5-year trough of $24.4 million in Q4 2020.
  • In the last 5 years, Volitionrx's Long-Term Deferred Tax had a median value of $30.9 million in 2022 and averaged $31.9 million.
  • Per our database at Business Quant, Volitionrx's Long-Term Deferred Tax surged by 356.21% in 2021 and then surged by 2194.89% in 2022.
  • Quarter analysis of 5 years shows Volitionrx's Long-Term Deferred Tax stood at $24.4 million in 2020, then grew by 3.56% to $25.3 million in 2021, then grew by 21.95% to $30.9 million in 2022, then increased by 20.31% to $37.1 million in 2023, then increased by 12.9% to $41.9 million in 2024.
  • Its Long-Term Deferred Tax stands at $41.9 million for Q4 2024, versus $37.1 million for Q4 2023 and $30.9 million for Q4 2022.